<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000302451">
  <TermName>anagrelide</TermName>
  <TermPronunciation>(an-AG-re-lide)</TermPronunciation>
  <TermDefinition>
    <DefinitionText>A drug that is used to decrease the number of platelets in the blood in order to prevent blood clotting.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <MediaLink ref="CDR0000710200" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;anagrelide&quot;" language="en" id="_3"/>
  <MediaLink ref="CDR0000710199" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;anagrelida&quot;" language="es" id="_4"/>
  <SpanishTermName>anagrelida</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Medicamento que se usa para disminuir la cantidad de plaquetas en la sangre a fin de impedir que la sangre se coagule.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateFirstPublished>2003-04-23</DateFirstPublished>
</GlossaryTerm>
